Mitja Jevnikar

4.7k total citations · 1 hit paper
54 papers, 1.4k citations indexed

About

Mitja Jevnikar is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Mitja Jevnikar has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 24 papers in Cardiology and Cardiovascular Medicine and 13 papers in Genetics. Recurrent topics in Mitja Jevnikar's work include Pulmonary Hypertension Research and Treatments (47 papers), Cardiovascular Function and Risk Factors (12 papers) and Cardiovascular Issues in Pregnancy (12 papers). Mitja Jevnikar is often cited by papers focused on Pulmonary Hypertension Research and Treatments (47 papers), Cardiovascular Function and Risk Factors (12 papers) and Cardiovascular Issues in Pregnancy (12 papers). Mitja Jevnikar collaborates with scholars based in France, Canada and United Kingdom. Mitja Jevnikar's co-authors include Xavier Jaïs, David Montani, Marc Humbert, Laurent Savale, Olivier Sitbon, Gérald Simonneau, Jason Weatherald, Athénaïs Boucly, Florence Parent and Vincent Cottin and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Mitja Jevnikar

51 papers receiving 1.4k citations

Hit Papers

Risk assessment, prognosis and guideline implementation i... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    2017 441 citations Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitja Jevnikar France 17 1.3k 901 235 133 132 54 1.4k
Mona Selej United States 14 1.1k 0.8× 739 0.8× 140 0.6× 140 1.1× 34 0.3× 35 1.2k
G. Meyer Brazil 10 798 0.6× 709 0.8× 139 0.6× 136 1.0× 421 3.2× 34 1.3k
Michał Florczyk Poland 14 871 0.7× 646 0.7× 196 0.8× 144 1.1× 78 0.6× 42 1.0k
Manuel López‐Meseguer Spain 16 672 0.5× 383 0.4× 144 0.6× 254 1.9× 83 0.6× 64 913
Takeyoshi Kunieda Japan 17 1.0k 0.8× 1.0k 1.1× 148 0.6× 239 1.8× 336 2.5× 60 1.6k
Allison Widlitz United States 15 1.7k 1.3× 1.1k 1.3× 398 1.7× 211 1.6× 31 0.2× 25 1.8k
Matthias Held Germany 17 890 0.7× 473 0.5× 108 0.5× 82 0.6× 230 1.7× 62 1.0k
Martin Doelberg Switzerland 10 793 0.6× 376 0.4× 75 0.3× 132 1.0× 78 0.6× 15 1.2k
Emanuele Romeo Italy 22 1.0k 0.8× 982 1.1× 70 0.3× 191 1.4× 22 0.2× 64 1.4k
Anjali Vaidya United States 16 824 0.6× 699 0.8× 70 0.3× 189 1.4× 95 0.7× 58 1.1k

Countries citing papers authored by Mitja Jevnikar

Since Specialization
Citations

This map shows the geographic impact of Mitja Jevnikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitja Jevnikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitja Jevnikar more than expected).

Fields of papers citing papers by Mitja Jevnikar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitja Jevnikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitja Jevnikar. The network helps show where Mitja Jevnikar may publish in the future.

Co-authorship network of co-authors of Mitja Jevnikar

This figure shows the co-authorship network connecting the top 25 collaborators of Mitja Jevnikar. A scholar is included among the top collaborators of Mitja Jevnikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitja Jevnikar. Mitja Jevnikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sitbon, Olivier, Athénaïs Boucly, Jason Weatherald, et al.. (2025). Drugs targeting novel pathways in pulmonary arterial hypertension. European Respiratory Journal. 66(2). 2401830–2401830. 2 indexed citations
2.
Bertoletti, Laurent, Athénaïs Boucly, Ségolène Turquier, et al.. (2025). Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 86(13). 982–995.
3.
Kopeć, Grzegorz, Paul R. Forfia, Kohtaro Abe, et al.. (2024). Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY). Pulmonary Circulation. 14(1). e12330–e12330. 6 indexed citations
4.
Boucly, Athénaïs, Antoine Beurnier, Xavier Jaïs, et al.. (2024). Outcomes and risk assessment in pulmonary veno-occlusive disease. ERJ Open Research. 10(1). 612–2023. 7 indexed citations
5.
Skoro‐Sajer, Nika, Karen Sheares, Paul R. Forfia, et al.. (2024). Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY). Pulmonary Circulation. 14(2). e12406–e12406. 1 indexed citations
6.
Kim, Nick H., Andrea Maria D’Armini, Marion Delcroix, et al.. (2024). Chronic thromboembolic pulmonary disease. European Respiratory Journal. 64(4). 2401294–2401294. 25 indexed citations
7.
Boucly, Athénaïs, Antoine Beurnier, Ségolène Turquier, et al.. (2024). Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension. European Respiratory Journal. 64(3). 2400197–2400197. 13 indexed citations
8.
Khouri, Charles, Xavier Jaïs, Laurent Savale, et al.. (2024). Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors. European Respiratory Journal. 63(6). 2302158–2302158. 7 indexed citations
9.
Fadel, Élie, Benoît Gérardin, Dominique Fabre, et al.. (2024). Balloon pulmonary angioplasty for proximal chronic thromboembolic pulmonary hypertension in patients ineligible for pulmonary endarterectomy. Pulmonary Circulation. 14(3). e12432–e12432. 1 indexed citations
10.
Cullivan, Sarah, Athénaïs Boucly, Mitja Jevnikar, et al.. (2023). ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly. ERJ Open Research. 10(1). 847–2023. 1 indexed citations
11.
Forfia, Paul R., Amélie Beaudet, Virginie Gressin, et al.. (2023). Diagnosis of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) by Cardiologists and Pulmonologists - a Global Cross-Sectional Scientific Survey (CLARITY). A2012–A2012. 1 indexed citations
12.
Savale, Laurent, Peter Dorfmüller, Athénaïs Boucly, et al.. (2023). Sarcoidosis-Associated Pulmonary Hypertension. Clinics in Chest Medicine. 45(1). 185–197. 5 indexed citations
13.
Jevnikar, Mitja, et al.. (2022). Balloon pulmonary angioplasty: are we there yet? Lessons learned and unanswered questions. Breathe. 18(4). 220217–220217. 3 indexed citations
14.
Boucly, Athénaïs, Jason Weatherald, Laurent Savale, et al.. (2021). External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. European Respiratory Journal. 59(6). 2102419–2102419. 100 indexed citations
15.
Seferian, Andrei, Xavier Jaïs, Mitja Jevnikar, et al.. (2019). Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension. Respiratory Medicine and Research. 76. 48–53. 5 indexed citations
16.
Taniguchi, Yu, Xavier Jaïs, Mitja Jevnikar, et al.. (2019). Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation. 38(8). 833–842. 51 indexed citations
17.
Weatherald, Jason, Athénaïs Boucly, D. S. Chemla, et al.. (2017). Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Circulation. 137(7). 693–704. 141 indexed citations
18.
Godinas, Laurent, C.H. Sattler, Edmund Lau, et al.. (2017). Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation. 36(11). 1234–1242. 33 indexed citations
19.
Confalonieri, Marco, et al.. (2015). Opening of a Respiratory Intermediate Care Unit in a General Hospital: Impact on Mortality and Other Outcomes. Respiration. 90(3). 235–242. 26 indexed citations
20.
Confalonieri, Marco, et al.. (2015). To use or not to use corticosteroids for pneumonia? A clinician’s perspective. Monaldi Archives for Chest Disease. 77(2). 94–101. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona Selej Breakdown of academic impact, for papers by G. Meyer Breakdown of academic impact, for papers by Michał Florczyk Breakdown of academic impact, for papers by Manuel López‐Meseguer Breakdown of academic impact, for papers by Takeyoshi Kunieda Breakdown of academic impact, for papers by Allison Widlitz Breakdown of academic impact, for papers by Matthias Held Breakdown of academic impact, for papers by Martin Doelberg Breakdown of academic impact, for papers by Emanuele Romeo Breakdown of academic impact, for papers by Anjali Vaidya
Rankless by CCL
2026